A detailed history of American Portfolios Advisors transactions in Staar Surgical CO stock. As of the latest transaction made, American Portfolios Advisors holds 493 shares of STAA stock, worth $12,310. This represents 0.0% of its overall portfolio holdings.

Number of Shares
493
Holding current value
$12,310
% of portfolio
0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Mar 17, 2023

BUY
$70.55 - $111.58 $34,781 - $55,008
493 New
493 $34.8 Million
Q2 2022

Mar 20, 2023

BUY
$50.24 - $80.48 $2,512 - $4,024
50 Added 10.14%
543 $38.5 Million
Q1 2022

Mar 21, 2023

BUY
$57.98 - $93.5 $2,899 - $4,675
50 Added 10.14%
543 $43.4 Million
Q4 2021

Mar 21, 2023

BUY
$88.02 - $127.79 $4,401 - $6,389
50 Added 10.14%
543 $49.6 Million
Q3 2021

Mar 22, 2023

BUY
$122.75 - $162.68 $14,116 - $18,708
115 Added 23.33%
608 $78.1 Million
Q2 2021

Mar 22, 2023

BUY
$105.76 - $154.96 $12,162 - $17,820
115 Added 23.33%
608 $92.7 Million
Q1 2021

Mar 22, 2023

BUY
$78.5 - $126.48 $9,027 - $14,545
115 Added 23.33%
608 $64.1 Million
Q4 2020

Mar 22, 2023

BUY
$55.93 - $82.78 $5,872 - $8,691
105 Added 21.3%
598 $47.4 Million
Q3 2020

Mar 22, 2023

BUY
$45.65 - $61.81 $9,358 - $12,671
205 Added 41.58%
698 $39.5 Million
Q2 2020

Mar 24, 2023

BUY
$29.15 - $61.54 $3,876 - $8,184
133 Added 26.6%
633 $39 Million
Q1 2020

Mar 24, 2023

BUY
$25.01 - $42.4 $175 - $296
7 Added 1.42%
500 $16.1 Million
Q4 2019

Mar 24, 2023

BUY
$24.55 - $38.13 $62,700 - $97,384
2,554 Added 518.05%
3,047 $107 Million
Q3 2019

Mar 24, 2023

SELL
$25.78 - $34.8 $18,149 - $24,499
-704 Reduced 17.01%
3,435 $88.6 Million
Q2 2019

Mar 24, 2023

BUY
$23.08 - $37.01 $84,149 - $134,938
3,646 Added 739.55%
4,139 $122 Million
Q1 2019

Mar 24, 2023

BUY
$27.81 - $40.78 $56,454 - $82,783
2,030 Added 411.76%
2,523 $86.3 Million

Others Institutions Holding STAA

About STAAR SURGICAL CO


  • Ticker STAA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 48,038,300
  • Market Cap $1.2B
  • Description
  • STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatis...
More about STAA
Track This Portfolio

Track American Portfolios Advisors Portfolio

Follow American Portfolios Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Portfolios Advisors, based on Form 13F filings with the SEC.

News

Stay updated on American Portfolios Advisors with notifications on news.